Manola Cuellar-Herrera

December 7, 2023

Cannabidiol Modifies the Glutamate Over-Release in Brain Tissue of Patients and Rats with Epilepsy: A Pilot Study

Abstract Drug-resistant epilepsy (DRE) is associated with high extracellular levels of glutamate. Studies support the idea that cannabidiol (CBD) decreases…

December 19, 2022

Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence

Abstract The use of Cannabis for medicinal purposes has been documented since ancient times, where one of its principal cannabinoids…

December 15, 2020

Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy

Abstract Experimental evidence indicates that cannabidiol (CBD) induces anxiolytic and antiepileptic effects through the activation of 5-HT1A receptors. These receptors…